These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M; Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis. Matsunaga S; Kishi T; Iwata N Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25548104 [TBL] [Abstract][Full Text] [Related]
5. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982 [TBL] [Abstract][Full Text] [Related]
6. Cognitive symptoms of Alzheimer's disease: clinical management and prevention. Joe E; Ringman JM BMJ; 2019 Dec; 367():l6217. PubMed ID: 31810978 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Takeda A; Loveman E; Clegg A; Kirby J; Picot J; Payne E; Green C Int J Geriatr Psychiatry; 2006 Jan; 21(1):17-28. PubMed ID: 16323253 [TBL] [Abstract][Full Text] [Related]
9. Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia. Fink HA; Linskens EJ; MacDonald R; Silverman PC; McCarten JR; Talley KMC; Forte ML; Desai PJ; Nelson VA; Miller MA; Hemmy LS; Brasure M; Taylor BC; Ng W; Ouellette JM; Sheets KM; Wilt TJ; Butler M Ann Intern Med; 2020 May; 172(10):656-668. PubMed ID: 32340037 [TBL] [Abstract][Full Text] [Related]
10. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Wattmo C; Minthon L; Wallin ÅK Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213 [TBL] [Abstract][Full Text] [Related]
11. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study. Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929 [TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases. Zhang DM; Ye JX; Mu JS; Cui XP J Geriatr Psychiatry Neurol; 2017 Jan; 30(1):50-59. PubMed ID: 28248558 [TBL] [Abstract][Full Text] [Related]
14. Current status and future promise of pharmacotherapeutic strategies for Alzheimer's disease. Standridge JB J Am Med Dir Assoc; 2005; 6(3):194-9. PubMed ID: 15894249 [TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Beier MT Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151 [TBL] [Abstract][Full Text] [Related]
17. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of Alzheimer's disease]. Johannsen P Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609 [TBL] [Abstract][Full Text] [Related]